SCHEMBL23809307

SCHEMBL23809307

CC(C)c1ccc(OCc2ccccc2)c2c1cc(C(=O)O)n2C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 3/20 0.50
SRD5A1 P18405 1/20 0.50
GLRA1 P23415 2/20 0.44
KMT2A Q03164 1/20 0.43
MRGPRX4 Q96LA9 2/20 0.43
RXRA P19793 1/20 0.42
FOLH1 Q04609 1/20 0.41
FFAR4 Q5NUL3 1/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGER1 P34995 1/20 0.38
POLB P06746 2/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26581296 0.85 SRD5A2 (0.57) SRD5A2SRD5A1KMT2AMRGPRX4RXRA
SCHEMBL27252502 0.81 SRD5A2 (0.50) SRD5A2SRD5A1KMT2AMRGPRX4FOLH1
SCHEMBL23809247 0.77 SRD5A2 (0.59) SRD5A2SRD5A1GLRA1KMT2AMRGPRX4
SCHEMBL3160643 0.77 SRD5A2 (0.61) SRD5A2SRD5A1KMT2AMRGPRX4RXRA
SCHEMBL5005325 0.74 SRD5A2 (0.61) SRD5A2SRD5A1KMT2AMRGPRX4NPC1
SCHEMBL23809185 0.74 KMT2A (0.40) SRD5A2SRD5A1KMT2AKDM4EHPGD
SCHEMBL19332196 0.74 SRD5A2 (0.58) SRD5A2SRD5A1KMT2AMRGPRX4FOLH1
SCHEMBL23799927 0.74 KMT2A (0.45) SRD5A2SRD5A1KMT2AMRGPRX4FOLH1
SCHEMBL3918347 0.72 GLRA1 (0.59) GLRA1KMT2AMRGPRX4RXRANPC1
SCHEMBL7884800 0.72 KMT2A (0.43) SRD5A2SRD5A1KMT2AMRGPRX4FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 SRD5A2 4675/4885SRD5A1 4570/4885GLRA1 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.